Craft

Yabao Pharmaceutical

Stock Price

¥6.3

2024-05-23

Market Capitalization

¥4.6 B

2024-05-23

Revenue

¥2.6 B

FY, 2022

Yabao Pharmaceutical Summary

Company Summary

Overview
Yabao Pharmaceutical Group ( 亚宝药业) is a company that specializes in the production, logistics, and distribution of medicines. It focuses on pediatrics, female health, cardiovascular diseases, and other therapeutic areas.
Type
Public
Status
Active
Founded
1978
HQ
Yuncheng Shi, CN | view all locations
Website
http://www.yabao.com.cn/
Cybersecurity rating
Sectors

Key People

  • Ren Wuxian

    Ren Wuxian, Chairman

    • Peng Wang
    • Sheldon Huang

    Operating MetricsView all

    Products

    300

    Sep, 2023

    Research and Development Centers

    4

    Sep, 2023

    Production Bases

    9

    Sep, 2023

    LocationsView all

    4 locations detected

    • Yuncheng Shi, Shanxi Sheng HQ

      China

      No. 1, Industrial Avenue, Fenglingdu Economic Development Zone,

    • Beijing, Beijing Shi

      China

      11TH Floor, Building, 2 Tianhua N St

    • Yuncheng, Shanxi

      China

      Ruicheng County

    • Yuncheng Shi, Shanxi Sheng

      China

      Yongle South Road, Ruicheng County

    Yabao Pharmaceutical Financials

    Summary Financials

    Revenue (Q3, 2023)
    ¥678.4M
    Gross profit (Q3, 2023)
    ¥364.7M
    Net income (Q3, 2023)
    ¥45.9M
    Cash (Q3, 2023)
    ¥583.4M
    EBIT (Q3, 2023)
    ¥54.1M
    Enterprise value
    $4.3B

    Footer menu